Asian Journal of Orthopaedic Research

A Case Study of Secondary Synovial Osteochondromatosis of Knee

Mohit Gera — 2022-09-23

Synovial osteochondromatosis (SOC) is a proliferative synovial disease. Which has a rare incidence and presents as numerous osteo-cartilaginous nodules in bursae, synovial joints and tendon sheaths. Diagnostic modalities for synovial chondromatosis include radiographs, CT scan or MRI, with definitive characteristics being determined by histological examination. Therapeutic options commonly include either arthroscopic or open procedures which prevent further articular and peri‑articular damage and abolish symptoms The following case report describes a 42 year male patient presenting with a secondary synovial osteochondromatosis of knee managed successfully with open procedure for the removal of the loose bodies.

Spine Implant Failure after C1-C2 Fixation

Evsukov Alex — 2022-11-23

The paper presents two clinical cases of the patients with different congenital craniovertebral junction deformities who developed rare delayed complications after the treatment and provides critical analysis of related literature data. CAAD is a complex multiplanar deformation, whose treatment requires a differential approach and depends on a kind of congenital anomalies and a load placed on instrumentation fixing points. Maximally symmetric positioning of the implants can help to avoid the recurrence or formation of a new anomaly in the postoperative period. A facet joint block prevents the formation of postoperative lateral atlantoaxial dislocation (LAAD).

Efficiency of Therapy with High Concentrations of Topic NSAIDs in Patients with Hip Osteoarthritis

Dmytro Grebeniuk — 2022-09-05

Aims: The aim of the study was to evaluate the effectiveness of therapy with high concentrations of topical NSAIDs in patients with hip osteoarthritis, depending on the volume of local fat deposits.

Materials and Methods: The study included 108 patients with a confirmed diagnosis of hip osteoarthritis. All patients were randomly divided into 2 large groups - according to the criteria for the volume of subcutaneous fat in the hip joint – patients with a skinfold thickness of 2 cm or less (group 1, n=68) and patients with a skinfold thickness of more than 2 cm (group 2, n=40). In addition, according to the used medication, the patients of each group were randomly divided equally into subgroups a (5% Ketoprofen gel) and b (5% Diclofenac sodium gel). The duration of treatment was 14 days. To assess the effectiveness of treatment, we studied the overall tolerability of the prescribed therapy, as well as the quality of life of patients at the time of inclusion in the study and after 14 days.

Results: In group 1 there was a significant improvement in the quality of life on all 5 scales of the questionnaire. When pairwise comparison of the studied parameters after the treatment, in the group of patients receiving the topical Diclofenac, the quality of life on all scales of the questionnaire was significantly better than in patients receiving Ketoprofen. All patients in group 2 showed a slight improvement in the quality of life in all parameters. The change in the studied indicators was not statistically significant and did not depend on the choice of topical NSAIDs.

Conclusion: Diclofenac has been shown to be more effective than Ketoprofen in patients with weak localized fat deposits. The efficiency of both drugs was insignificant in patients with pronounced fat deposits in the hip joint area.

Functional Outcome of Unstable Inter Trochanteric Fractures with Osteoporosis Treated with Type II Proximal Femoral Nail

Roshan Jaiswal — 2022-09-14

Introduction: With increasing longevity of the population, the proportion of elderly patients experiencing osteoporosis related complications has significantly increased. The incidence of femoral intertrochanteric fractures has also increased year by year. 45% of all hip fractures are intertrochanteric fractures and 35–40% of these fractures are unstable three or four part fractures and associated with high rates of morbidity and mortality.

Materials and Methods: The present studyis a cohort study to show the Functional outcome of unstable inter trochanteric fractures treated with PFNA II in elderly osteoporotic patients, and to note the radiological union in the treated people

Results: In our study, the mean Age of patients age group is 71-80,6(40%) and 81-90, 6 (40%), followed by 03 (20%) patients were 61-70 years. The means of age is 70.04±12.42. In the present study & observation was done by higher Harris Hip score (HHS). Their intergroup comparison of score showed differences at every single follow-up. Additionally, the minimal blood loss, length of surgery, and a smaller incision, & Average hospital stay revealed no substantial variations.

Conclusion: PFNA2 is a significant advancement in the treatment of unstable trochanteric fractures which has the unique advantages of closed reduction, preservation of fracture hematoma, less tissue damage, early rehabilitation and early return to work. Osteosynthesis using a PFNA2, used in unstable trochanteric fractures, resulted in low rates of clinical complications, excellent stabilization, few mechanical complications and adequate functional results.